SH2B3


Summary: This gene encodes a member of the SH2B adaptor family of proteins, which are involved in a range of signaling activities by growth factor and cytokine receptors. The encoded protein is a key negative regulator of cytokine signaling and plays a critical role in hematopoiesis. Mutations in this gene have been associated with susceptibility to celiac disease type 13 and susceptibility to insulin-dependent diabetes mellitus. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in SH2B3


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP TAS GO:0007596 blood coagulation
BP IEA GO:0009967 positive regulation of signal transduction
BP IEA GO:0030154 cell differentiation
BP IEA GO:0035162 embryonic hemopoiesis
BP IBA GO:0035556 intracellular signal transduction
BP IEA GO:0035556 intracellular signal transduction
Showing 1 to 6 of 11 rows rows per page

Gene expression in normal tissue: SH2B3

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in SH2B3


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-109582 Hemostasis
reactome R-HSA-1433557 Signaling by SCF-KIT
reactome R-HSA-1433559 Regulation of KIT signaling
reactome R-HSA-162582 Signal Transduction
reactome R-HSA-9006934 Signaling by Receptor Tyrosine Kinases
reactome R-HSA-983231 Factors involved in megakaryocyte development and platelet production
Showing 1 to 6 of 12 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD932 JAK inhibitor 3
iGMDRD574 Ruxolitinib 4
iGMDRD949 mTOR inhibitor 2
Showing 1 to 3 of 3 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in SH2B3

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​